Abstract: A communications headset in which a microphone at the end of a support boom can be adjustably secured in a position selected by the wearer and can accommodate a variety of wearers. The headset may include a boom arm clip configured to receive a boom arm retaining a microphone. The boom arm clip can include an opening, and the opening may include a pair of grooves, the pair of grooves together can define a channel sized to fit and retain the boom arm therein. The headset may also include an adjusting knob, which can secure the boom arm clip in order to adjustably fix the boom arm in a number of positions on the headset to accommodate for different sized users.

Abstract: A communications headset in which a microphone at the end of a support boom can be adjustably secured in a position selected by the wearer and can accommodate a variety of wearers. The headset may include a boom arm clip configured to receive a boom arm retaining a microphone. The boom arm clip can include an opening, and the opening may include a pair of grooves, the pair of grooves together can define a channel sized to fit and retain the boom arm therein. The headset may also include an adjusting knob, which can secure the boom arm clip in order to adjustably fix the boom arm in a number of positions on the headset to accommodate for different sized users.

Abstract: The invention provides, in part, novel SV-BR cancer cell lines. The invention provides a novel cell line SV-BR-1 deposited under ATCC PTA-1712 and SV-BR-1-GM cells deposited under ATCC PTA-1713. The invention further relates to therapeutic and non-therapeutic uses of the novel cell lines. Therapeutic uses include the use of SV-BR cell lines as cancer vaccines, and in particular, or the treatment of cancer.

Abstract: The invention provides, in part, novel SV-BR cancer cell lines. The invention provides a novel cell line SV-BR-1 deposited under ATCC ______, and SV-BR-1-GM cells deposited under ATCC ______. The invention further relates to therapeutic and non-therapeutic uses of the novel cell lines. Therapeutic uses include the use of SV-BR cell lines as cancer vaccines, and in particular, or the treatment of cancer.